Prostatype Genomics AB(SE:PROGEN)
kr 0.10-0.00 (-2.02%)
SE:PROGEN
Prostatype Genomics AB financials statements
kr 0.10
At close:-0.00 (-2.02%)
Want to see SE:PROGEN full AI Analyst Report?
Prostatype Genomics AB (PROGEN) Ratios
0 Followers
Prostatype Genomics AB Ratios
SE:PROGEN's free cash flow for Q2 2026 was kr-7.10M. For the 2026 fiscal year, SE:PROGEN's free cash flow was decreased by kr-16.00K and operating cash flow was kr-7.09M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.44 | 1.39 | 1.06 | 3.27 | 6.29 |
| Quick Ratio | 0.43 | 1.38 | 1.05 | 3.26 | 6.26 |
| Cash Ratio | 0.37 | 1.11 | 0.11 | 1.11 | 2.87 |
| Solvency Ratio | -1.74 | -4.60 | -1.61 | -5.66 | -3.62 |
| Operating Cash Flow Ratio | -0.98 | -5.26 | -1.19 | -6.39 | -4.69 |
| Short-Term Operating Cash Flow Coverage | -4.49 | -667.30 | -2.51 | -69.23 | -40.20 |
| Net Current Asset Value | kr -13.69M | kr 3.32M | kr 1.36M | kr 9.37M | kr 17.29M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.00 | 0.24 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.20 | 0.00 | 0.47 | 0.03 | 0.04 |
| Debt-to-Capital Ratio | 0.17 | 0.00 | 0.32 | 0.03 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Financial Leverage Ratio | 1.92 | 1.25 | 1.99 | 1.18 | 1.12 |
| Debt Service Coverage Ratio | -5.34 | -21.44 | -2.89 | -33.61 | -32.11 |
| Interest Coverage Ratio | -24.20 | -24.36 | -25.49 | -72.26 | -190.79 |
| Debt to Market Cap | 0.52 | 0.00 | 0.04 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.20 | 0.58 | 3.84 | 0.55 | 0.92 |
| Net Debt to EBITDA | 0.10 | 0.25 | -0.24 | 0.15 | 0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | -6332.66% | 963.82% | 274.93% | 100.00% | 25096.42% |
| EBIT Margin | -6579.12% | -19785.93% | -2942.11% | -4200.59% | -155482.65% |
| EBITDA Margin | -6210.94% | -18791.96% | -2803.83% | -3921.82% | -154597.82% |
| Operating Profit Margin | -6579.12% | -20529.15% | -2894.32% | -4200.44% | -155482.65% |
| Pretax Profit Margin | -7492.09% | -20628.64% | -3055.68% | -4258.71% | -156297.58% |
| Net Profit Margin | -7492.09% | -20628.64% | -3055.68% | -4258.71% | -156297.58% |
| Continuous Operations Profit Margin | -7492.09% | -20628.64% | -3055.68% | -4258.71% | -156297.58% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 113.88% | 100.48% | 105.57% | 101.39% | 100.52% |
| Return on Assets (ROA) | -87.50% | -97.81% | -84.18% | -93.98% | -38.88% |
| Return on Equity (ROE) | -167.75% | -122.65% | -167.93% | -111.23% | -43.53% |
| Return on Capital Employed (ROCE) | -147.31% | -122.06% | -158.64% | -107.78% | -42.28% |
| Return on Invested Capital (ROIC) | -122.78% | -121.82% | -108.00% | -106.19% | -41.83% |
| Return on Tangible Assets | -384.41% | -323.16% | -159.11% | -204.26% | -72.36% |
| Earnings Yield | -439.10% | -123.13% | -13.44% | -1.79% | -0.36% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.40 | 0.11 | 0.89 | 0.27 | 0.01 |
| Payables Turnover | 13.97 | -0.68 | -0.25 | 6.18 | -2.13 |
| Inventory Turnover | 489.87 | -18.09 | -11.68 | 306.57 | -23.25 |
| Fixed Asset Turnover | 1.31 | 0.64 | 22.60 | 170.75 | 0.71 |
| Asset Turnover | 0.01 | 0.00 | 0.03 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | -0.11 | 0.08 | 0.24 | 0.05 | 0.00 |
| Cash Conversion Cycle | 893.26 | 3789.54 | 1834.71 | 1276.51 | 39356.17 |
| Days of Sales Outstanding | 918.64 | 3273.99 | 412.11 | 1334.41 | 39200.34 |
| Days of Inventory Outstanding | 0.75 | -20.17 | -31.24 | 1.19 | -15.70 |
| Days of Payables Outstanding | 26.13 | -535.72 | -1453.84 | 59.10 | -171.53 |
| Operating Cycle | 919.39 | 3253.82 | 380.87 | 1335.60 | 39184.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.70 | -14.89 | -8.47 | -11.99 | -10.95 |
| Free Cash Flow Per Share | -0.71 | -17.50 | -10.95 | -11.99 | -12.65 |
| Dividend Paid and CapEx Coverage Ratio | -92.25 | -5.69 | -3.40 | 0.00 | -6.43 |
| Capital Expenditure Coverage Ratio | -92.25 | -5.69 | -3.40 | 0.00 | -6.43 |
| Operating Cash Flow Coverage Ratio | -4.49 | -667.30 | -2.50 | -31.94 | -12.69 |
| Operating Cash Flow to Sales Ratio | -40.07 | -224.67 | -21.49 | -40.55 | -1607.82 |
| Free Cash Flow Yield | -237.38% | -157.69% | -12.23% | -1.70% | -0.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.23 | -0.81 | -7.44 | -55.97 | -279.31 |
| Price-to-Sales (P/S) Ratio | 17.06 | 167.53 | 227.40 | 2383.59 | 436559.26 |
| Price-to-Book (P/B) Ratio | 0.38 | 1.00 | 12.50 | 62.25 | 121.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.42 | -0.63 | -8.18 | -58.79 | -234.99 |
| Price-to-Operating Cash Flow Ratio | -0.43 | -0.75 | -10.58 | -58.79 | -271.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.06 | 1.70 | -3.05 | 4.84 |
| Enterprise Value Multiple | -0.17 | -0.64 | -8.35 | -60.63 | -281.83 |
| Enterprise Value | 6.37M | 23.99M | 317.33M | 1.62B | 4.36B |
| EV to EBITDA | -0.17 | -0.64 | -8.35 | -60.63 | -281.83 |
| EV to Sales | 10.72 | 120.53 | 234.02 | 2377.82 | 435703.00 |
| EV to Free Cash Flow | -0.26 | -0.46 | -8.42 | -58.64 | -234.53 |
| EV to Operating Cash Flow | -0.27 | -0.54 | -10.89 | -58.64 | -270.99 |
| Tangible Book Value Per Share | -0.38 | 1.40 | 0.43 | 4.09 | 11.78 |
| Shareholders’ Equity Per Share | 0.79 | 11.14 | 7.17 | 11.32 | 24.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.07 | 0.39 | 0.30 | 0.01 |
| Net Income Per Share | -1.32 | -13.67 | -12.04 | -12.59 | -10.64 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.14 | 1.04 | 1.04 | 1.01 | 1.01 |
| Research & Development to Revenue | 2.46 | 11.11 | 2.38 | 5.14 | 148.81 |
| SG&A to Revenue | 0.00 | 78.94 | 0.00 | 19.75 | 849.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.53 | 1.09 | 0.70 | 0.95 | 1.03 |
Currency in SEK
